The diagnostic efficiency of IgA aCL was evaluated according to the ROC curves (Figure 2) depending on the presence of thrombosis (a), pregnancy morbidity (b), and a confirmed diagnosis of APS (c). This evidence concerns the gene CD79A and Venous thrombosis.